Mary Ann Johnston
Profile
Mary Ann Johnston worked as a Director of Medical Science Liaisons at Actelion Pharmaceuticals Australia Pty Ltd.
and as a VP of Medical Affairs and Clinical Operations at GTx, Inc. She holds a doctorate degree from McWhorter School of Pharmacy.
Former positions of Mary Ann Johnston
| Companies | Position | End |
|---|---|---|
| Actelion Pharmaceuticals Australia Pty Ltd. | Corporate Officer/Principal | - |
GTx, Inc.
 GTx, Inc. Pharmaceuticals: MajorHealth Technology GTx, Inc. is a a biopharmaceutical company, which engages in the discovery, development, and commercialization of small molecules for the treatment of muscle-related diseases and other serious medical conditions. It focuses on developing selective androgen receptor modulators and selective androgen receptor degrader for the treatment of breast cancer, stress urinary incontinence, Duchenne muscular dystrophy, and prostate cancer. The company was founded by Marc Steven Hanover and Mitchell Shuster Steiner on September 24, 1997 and is headquartered in Memphis, TN. | Corporate Officer/Principal | - |
Training of Mary Ann Johnston
| Mcwhorter School of Pharmacy | Doctorate Degree |
Experiences
Positions held
Linked companies
| Private companies | 2 |
|---|---|
GTx, Inc.
GTx, Inc. Pharmaceuticals: MajorHealth Technology GTx, Inc. is a a biopharmaceutical company, which engages in the discovery, development, and commercialization of small molecules for the treatment of muscle-related diseases and other serious medical conditions. It focuses on developing selective androgen receptor modulators and selective androgen receptor degrader for the treatment of breast cancer, stress urinary incontinence, Duchenne muscular dystrophy, and prostate cancer. The company was founded by Marc Steven Hanover and Mitchell Shuster Steiner on September 24, 1997 and is headquartered in Memphis, TN. | Health Technology |
| Actelion Pharmaceuticals Australia Pty Ltd. |
- Stock Market
- Insiders
- Mary Ann Johnston